Switching Undetectables to Selzentry

Summary

Switching Undetectables to Selzentry is a clinical trial^[1].

Key Facts

• Switching Undetectables to Selzentry is in the country of United States^[2].
• Switching Undetectables to Selzentry's instance of is recorded as clinical trial^[3].
• Switching Undetectables to Selzentry's start time is recorded as +2013-01-31T00:00:00Z^[4].
• Switching Undetectables to Selzentry's end time is recorded as +2013-12-31T00:00:00Z^[5].
• Switching Undetectables to Selzentry's contributor to the creative work or subject is recorded as GSK^[6].
• Switching Undetectables to Selzentry's number of participants is recorded as {'unit': '1', 'amount': '+31'}^[7].
• Switching Undetectables to Selzentry's title is recorded as A Study in HIV+ Patients With CCR5-tropic Virus and Undetectable Viral Load on a First, Non-Selzentry®-Containing Regimen, Switching Them to Once-daily Selzentry® (600mg qd) Plus the Same 2 NRTIs Previously Administered^[8].
• Switching Undetectables to Selzentry's short name is recorded as SUDS^[9].
• Switching Undetectables to Selzentry's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Switching Undetectables to Selzentry's ClinicalTrials.gov ID is recorded as NCT01866267^[11].
• Switching Undetectables to Selzentry's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}^[12].
• Switching Undetectables to Selzentry's research intervention is recorded as HIV integrase inhibitors^[13].
• Switching Undetectables to Selzentry's clinical trial phase is recorded as phase IV clinical trial^[14].
• Switching Undetectables to Selzentry's research site is recorded as St. Hope Foundation^[15].
• Switching Undetectables to Selzentry's study type is recorded as interventional study^[16].